Flaxseed is a type of Food and its properties as follows :-
Active Compound Qty/100gram Qty/day (Min-Max) T_half (Min-Max) Peak value (Min-Max)       Qty/gm_Ref        Qty/gm_Url            Qty/day_Ref        Qty/day_Url            T_half_Ref        T_half_Url         Peak value_Ref       Peak value_Url     
Secoisolariciresinol diglucoside (SDG) 35-50 gm 288-288 (minute) 384-384 (minute) PDR for Herbal medicines. (2000) (4th ed.). U.S http://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/ Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/
Enterodiol 35-50 564-564 (minute) 1092-1092 (minute) PDR for Herbal medicines. (2000) (4th ed.). U.S. http://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/ Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/
Enterolactone 35-50 gm 792 (minute) 1542 (minute) PDR for Herbal medicines. (2000) (4th ed.). U.S. http://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/ Setchell, K., Brown, N., Zimmer-Nechemias, L., Wolfe, B., Jha, P. and Heubi, J. (2014). Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food & Function, 5(3), p.491. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996458/
Lignans 335 gm 35-50 gm PDR for Herbal medicines. (2000) (4th ed.). U.S. http://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf
Flaxseed is a type of Food and its properties as follows :-
Enhencer Effect Reference Url
Flaxseed is a type of Food and its properties as follows :-
Inhibitor Effect Ref Url
Flaxseed is a type of Food and its properties as follows :-
Dietry_product Type Temperature Ref_Temp Url_Temp

Pathway of Dietry Product


​   ► Medicine for Flaxseed as follows :-
Aliskiren Fumarate with same pathway,

  ►  Pathway with its reference as follows :-
  • Flaxseed peptide fractions act as renin inhibitors . --- (Udenigwe, C., Lin, Y., Hou, W., & Aluko, R. (2009). Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. Journal Of Functional Foods, 1(2), 199-207. doi:10.1016/j.jff.2009.01.009 )

  •   ►  URL --
  • http://www.sciencedirect.com/science/article/pii/S1756464609000103
  • Dietry Substance Interactions


    ​   ► Flaxseed interact with medicines having some effect as follows :-
    'Not Found'

    ContraIndication Dietry Substance


    ​   ► Flaxseed Contraindicate with medicines as follows :-
    'Not Found'